If you're eating less, moving more, and still not seeing the number on the scale go down, you may be wondering: "Why am I not ...

Eli Lilly and Co. shares surged after data showed its experimental weight-loss pill worked as well as the Ozempic shot.

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

Eli Lilly has seen positive results from a phase 3 trial of Orforglipron, the first-ever GLP-1 pill for weight loss and type ...

A pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss ...

A 24-year-old man shed 33 kilos in a holistic manner without resorting to any quick fixes. To know how he did it, read on., ...

The company's breakthrough puts the market one step closer to having an injection-free alternative for the treatment of ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

When it comes to weight loss, we live in an era that feels more influenced than investigated. We receive so much nutrition ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...